vs
Side-by-side financial comparison of Cars.com Inc. (CARS) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Cars.com Inc. is the larger business by last-quarter revenue ($183.9M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 1.9%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 1.0%).
Cars.com is an automotive classified website focused on the United States that launched in June 1998 and now is the second largest automotive classified site. It is also known for being the most expensive domain ever sold. It was sold in 2014 for $872 million Its headquarters are located in Chicago, Illinois. Cars.com also offers expert car reviews, news and research from its dedicated Editorial team.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CARS vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.9M | $168.4M |
| Net Profit | — | — |
| Gross Margin | — | — |
| Operating Margin | 11.8% | 50.6% |
| Net Margin | — | — |
| Revenue YoY | 1.9% | 143.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.12 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.9M | $168.4M | ||
| Q3 25 | $181.6M | $87.3M | ||
| Q2 25 | $178.7M | $82.4M | ||
| Q1 25 | $179.0M | $65.0M | ||
| Q4 24 | $180.4M | $69.1M | ||
| Q3 24 | $179.7M | $51.6M | ||
| Q2 24 | $178.9M | $73.8M | ||
| Q1 24 | $180.2M | $137.7M |
| Q4 25 | — | — | ||
| Q3 25 | $7.7M | $-31.3M | ||
| Q2 25 | $7.0M | $-12.7M | ||
| Q1 25 | $-2.0M | $-40.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $18.7M | $-29.5M | ||
| Q2 24 | $11.4M | $-61.9M | ||
| Q1 24 | $784.0K | $61.0M |
| Q4 25 | 11.8% | 50.6% | ||
| Q3 25 | 9.3% | -11.4% | ||
| Q2 25 | 8.5% | 8.6% | ||
| Q1 25 | 3.6% | -34.0% | ||
| Q4 24 | 11.0% | -6.4% | ||
| Q3 24 | 6.4% | -31.0% | ||
| Q2 24 | 5.3% | 3.5% | ||
| Q1 24 | 7.1% | 52.5% |
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | -35.9% | ||
| Q2 25 | 3.9% | -15.4% | ||
| Q1 25 | -1.1% | -62.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.4% | -57.2% | ||
| Q2 24 | 6.4% | -83.9% | ||
| Q1 24 | 0.4% | 44.3% |
| Q4 25 | $0.12 | $0.32 | ||
| Q3 25 | $0.12 | $-0.16 | ||
| Q2 25 | $0.11 | $-0.06 | ||
| Q1 25 | $-0.03 | $-0.21 | ||
| Q4 24 | $0.26 | $-0.14 | ||
| Q3 24 | $0.28 | $-0.15 | ||
| Q2 24 | $0.17 | $-0.33 | ||
| Q1 24 | $0.01 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $56.2M | $167.9M |
| Total DebtLower is stronger | $455.0M | — |
| Stockholders' EquityBook value | $472.5M | $-302.0M |
| Total Assets | $1.1B | $465.9M |
| Debt / EquityLower = less leverage | 0.96× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.2M | $167.9M | ||
| Q3 25 | $55.1M | $92.4M | ||
| Q2 25 | $27.7M | $86.1M | ||
| Q1 25 | $31.4M | $114.6M | ||
| Q4 24 | $50.7M | $144.8M | ||
| Q3 24 | $49.6M | $144.7M | ||
| Q2 24 | $29.1M | $189.3M | ||
| Q1 24 | $31.4M | $226.6M |
| Q4 25 | $455.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $460.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $472.5M | $-302.0M | ||
| Q3 25 | $477.6M | $-451.4M | ||
| Q2 25 | $483.2M | $-433.5M | ||
| Q1 25 | $489.9M | $-426.2M | ||
| Q4 24 | $511.5M | $-388.7M | ||
| Q3 24 | $502.4M | $-370.2M | ||
| Q2 24 | $496.9M | $-344.2M | ||
| Q1 24 | $481.4M | $-294.3M |
| Q4 25 | $1.1B | $465.9M | ||
| Q3 25 | $1.1B | $364.0M | ||
| Q2 25 | $1.1B | $347.1M | ||
| Q1 25 | $1.1B | $324.0M | ||
| Q4 24 | $1.1B | $343.8M | ||
| Q3 24 | $1.1B | $314.1M | ||
| Q2 24 | $1.1B | $352.3M | ||
| Q1 24 | $1.1B | $373.1M |
| Q4 25 | 0.96× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.90× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.1M | $45.2M |
| Free Cash FlowOCF − Capex | $36.7M | — |
| FCF MarginFCF / Revenue | 20.0% | — |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $147.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.1M | $45.2M | ||
| Q3 25 | $58.8M | $-4.3M | ||
| Q2 25 | $26.2M | $-31.4M | ||
| Q1 25 | $29.5M | $-22.6M | ||
| Q4 24 | $30.0M | $-35.0M | ||
| Q3 24 | $53.8M | $-35.3M | ||
| Q2 24 | $35.3M | $-7.2M | ||
| Q1 24 | $33.5M | $53.8M |
| Q4 25 | $36.7M | — | ||
| Q3 25 | $58.3M | — | ||
| Q2 25 | $23.7M | — | ||
| Q1 25 | $28.6M | — | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $52.8M | $-35.5M | ||
| Q2 24 | $34.9M | $-7.3M | ||
| Q1 24 | $32.8M | $53.8M |
| Q4 25 | 20.0% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 13.3% | — | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | 16.1% | — | ||
| Q3 24 | 29.4% | -68.7% | ||
| Q2 24 | 19.5% | -9.9% | ||
| Q1 24 | 18.2% | 39.0% |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.4% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 7.68× | — | ||
| Q2 25 | 3.74× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.87× | — | ||
| Q2 24 | 3.10× | — | ||
| Q1 24 | 42.69× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CARS
| Dealer | $164.4M | 89% |
| Sales Channel Through Oem And National | $16.2M | 9% |
| Sales Channel Through Other | $3.3M | 2% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
